Market Overview

Why Cellectar, Jaguar Health And More Are Moving Today

Share:
Why Cellectar, Jaguar Health And More Are Moving Today

Cellectar Biosciences (NASDAQ: CLRB) shares are trading lower on Wednesday after the company priced a $24.5 million offering at $1.35 per share.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development of targeted phospholipid drug conjugates for the treatment and imaging of cancer.

Cellectar Biosciences shares were trading down 31.41% at $1.90. The stock has a 52-week high of $3.33 and a 52-week low of $1.01.

Jaguar Health (NASDAQ: JAGX) shares are trading higher after the company signed an agreement with a secured lender involving the $6 million sale of royalty interest in Mytesi royalties.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products.

Jaguar Health shares were trading up 112.38% at 84 cents. The stock has a 52-week high of $1.08 and a 52-week low of 18 cents.

Voyager Therapeutics (NASDAQ: VYGR) shares are trading lower after the company late Tuesday announced that the FDA has notified Neurocrine Biosciences that it has placed a clinical hold on the RESTORE-1 clinical trial of NBIb-1817.

Voyager Therapeutics Inc is functional in the United States biotechnology industry. Its focus lies in the research and development of gene therapies for the cure of severe diseases of the central nervous system such as the Parkinson's, Huntington's, and Alzheimer's disease.

Voyager Therapeutics shares were trading down 10.85% at $8.05. The stock has a 52-week high of $15.17 and a 52-week low of $6.26.

Spectrum Pharmaceuticals (NASDAQ: SPPI) shares are trading lower after the company announced the pre-specified primary endpoint in its Phase 2 clinical trial evaluating poziotinib was not met in cohort 3.

Spectrum Pharmaceuticals Inc operates in the healthcare sector in the United States. As an oncology products manufacturer, it develops drugs to combat various kinds of tumors.

Spectrum Pharmaceuticals shares were trading down 8.12% at $3.90. The stock has a 52-week high of $8.77 and a 52-week low of $1.74.

 

Related Articles (CLRB + JAGX)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks Small Cap Movers Trading Ideas